June 11, 2019
Make fakes harder to take - Healthcare Purchasing News
In this Healthcare Purchasing News article published June 2019, Noel O’Hanlon, Genesis’ Founder and CEO, discusses a global approach to combating counterfeit medications, how unique identification and a digital closed-loop supply chain can provide effective safeguards for pharmaceuticals, providers and the patients who rely on safe medications. As a leading innovator of UDI track-and-trace programs, Genesis is uniquely positioned to support patient safety as products make their way from manufacturer to patient.
Read More